Trials / Sponsors / Herbert Lyerly
Herbert Lyerly
Academic / Other · 5 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Active Not Recruiting | Cancer Peptides Plus GM-CSF and Adjuvant in Breast Cancer Breast Cancer | Phase 1 | 2020-09-01 |
| Withdrawn | HS-201, an HSP90 Inhibitor-linked Verteporfin for Detection of Solid Malignancies Solid Tumor | Phase 1 | 2020-07-15 |
| Active Not Recruiting | Assessing the Immunogenicity of pING-hHER3FL Advanced Cancer | Phase 1 | 2020-07-13 |
| Active Not Recruiting | A Study to Evaluate Concurrent VRP-HER2 Vaccination and Pembrolizumab for Patients With Breast Cancer Breast Cancer, HER2+ Breast Cancer | Phase 2 | 2019-03-01 |
| Terminated | A Study of HS-196, an HSP90 Inhibitor-linked NIR Probe for Solid Malignancies Solid Tumor | Phase 1 | 2018-08-10 |